Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Total Current Liabilities (2016 - 2025)

Immucell's Total Current Liabilities history spans 16 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 9.84% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, down 9.84%, while the annual FY2025 figure was $4.0 million, 9.84% down from the prior year.
  • Total Current Liabilities reached $4.0 million in Q4 2025 per ICCC's latest filing, roughly flat from $4.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $4.6 million in Q2 2024 to a low of $2.0 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $3.5 million, with a median of $3.9 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: fell 14.47% in 2021, then skyrocketed 53.52% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $2.5 million in 2021, then rose by 21.21% to $3.1 million in 2022, then skyrocketed by 36.63% to $4.2 million in 2023, then increased by 5.12% to $4.4 million in 2024, then decreased by 9.84% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Total Current Liabilities are $4.0 million (Q4 2025), $4.0 million (Q3 2025), and $4.4 million (Q2 2025).